The independent source for health policy research, polling, and news.
7,941 - 7,960 of 15,249 Results
The Trump administration’s first health regulation would shorten the enrollment periods and make it harder for patients to get coverage outside of that annual signup period.
People who do not get insurance through their job or the government have long battled a difficult market.
The federal program paid $16 million in the first six months of 2016 to counsel 223,000 patients about treatment preferences in their last days.
As conservative physicians rise to more powerful positions in government, some question whether they speak for the nation’s doctors.
The president says Obamacare has been “a complete and total disaster,” and other Republicans see nothing but trouble. But a careful look at the arguments suggest the situation is more complicated.
Former FDA Commissioner Dr. Robert Califf shares his views about drug approvals, regulations and safety concerns after stepping down from the giant agency.
A federal judge in Texas last month issued a preliminary injunction barring the government from enforcing a rule allowing insurers to refuse to insure dialysis patients who get premium assistance from charity groups.
After hearing complaints about its high price, Marathon Pharmaceuticals is pausing the launch of an $89,000 drug for a rare disease.
Taking time to discuss the inevitable can help conquer a universal fear.
More than 6,000 workers had levels in their blood that could lead to heart, kidney or cognitive disease, according to state findings.
In remote parts of Montana, the Affordable Care Act has meant better health care for Native Americans and more job opportunities.
A new report finds that major insurers like Aetna and UnitedHealth submitted conflicting lists to the state that were off by thousands of doctors.
Citing a Kaiser Health News investigation, Senate Judiciary Committee Chairman Chuck Grassley vows to examine the orphan drug program and possible fixes.
A study of five states looks at the market conditions that make or break the health insurance marketplaces set up by the Affordable Care Act.
After a tough fight by Democrats, Senate Republicans confirmed Rep. Tom Price’s nomination to head the Department of Health and Human Services. He will have the authority to upend some current practices.
Lung cancer screening rates have not changed much even though the U.S. Preventive Services Task Force has recommended that smokers get checked, according to a new study.
The FDA has approved dozens of new cancer medications in recent years, but few offer the benefits that patients seek.
Republicans’ delay in finding common ground to repeal and replace the health law raises risks that coverage could shrink and rates rise even more, the industry says.
New advocacy groups like Indivisible California weigh strategies for long-haul political activism, including protests.
The first overhaul of federal regulations in almost 30 years for home health care agencies will require them to be much more responsive to what aging patients and their caregivers need or want.
© 2026 KFF